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Abstract 
Salmonellosis has become a major problem in developed and developing countries. It also represents an 
important public health concern worldwide.  As such, due to intense interest Salmonella research has gained 
great concern from scientific communities as well as the general public.  The purpose of this review is to discuss 
the historical perspective, classification and nomenclature, antibiotic and antimicrobial definition, mechanism of 
antibiotic resistance, integrons and antibiotic resistance Salmonella.  
 
1.  Introduction 
Nontyphoidal salmonellosis is caused by numerous Salmonella species other than serovars Typhi and Paratyphi.  
The genus Salmonella are facultative anaerobes, non-sporing, rod shape bacillus and Gram negative motile 
belonging to the family Enterobacteracae (Ellermeier and Slauch, 2006).  Morphologically Salmonella is rod 
shaped bacteria with diameter ranging from 0.7-1.5 μm and 2-5 μm in size with optimal growth condition of 37 
◦C (Ellermeier and Slauch, 2006).  
 
Salmonellosis represents a serious threat to public health resulting in considerable economic consequences in 
many parts of the world.  The emergence of antimicrobial-resistant Salmonella and other enteric pathogens has 
become a major concern.  The use of antimicrobials in therapeutic, prevention of disease and growth promotion 
in domestic livestock, can potentially lead to widespread dissemination of antimicrobial-resistant bacteria 
(Tollefson, 1997; Gomez-Lus, 1998; Witte, 1998).  
 
2.  Historical perspective of Salmonella 
As early as the 18th century, scientist developed interest on Salmonella as a potential etiological agent of typhoid 
fever (Cunha, 2004).  In 1873, William Budd diagnosed Typhoid fever in clinical patients, and this was the first 
time Salmonella was determined as a source of the infection for the disease (Ellermeier and Slauch, 2006).  Later 
on, Karl Eberth (1833-1926), discovered a rod-shaped organism in spleens and lymph nodes of a Typhoid fever 
patient.  Similarly, in the 18th century, George Gaffky (1850-1918) was credited for his successful cultivation of 
Salmonella serovars Typhi from a patient in Germany (Ellermeier and Slauch, 2006).  At the same time 
Salmonella Choleraesuis was isolated from porcine intestines in 1885; Theobald Smith (1859-1934) and Damon 
Elder Salmon (1850-1914) described the bacterium of swine Plague in 1886 which was published in the Second 
Annual Report of Bureau of Animal Industry (Enersen, 2007).  Finally, in 1990 a French bacteriologist, Joseph 
Léon Marcel Ligniéres suggested the adoption of the name “Salmonella” in honour of D.E. Salmon to 
encompass the entire genus (Enersen, 2007).  
 
3.  Salmonella Classification and Nomenclature 
Over the years, various methods for the nomenclature and classification of the Salmonella species, subspecies, 
subgenera and serotypes have been proposed.  Almost a century ago Kauffmann-White scheme classified 
Salmonella into three categories on the bases of serological identification of flagellar (H) antigens, somatic (O) 
antigens and virulence (Vi) capsular K antigens.  In the mid-1930s, the scheme was adopted by the International 
Association of Microbiologist (Scherer and Miller, 2001).  The antibodies agglutination specific for the various 
O antigens is employed to group Salmonellae into the 6 serogroups: A, B, C1, C2, D and E.  For instance, S. 
Paratyphi A, B, C and S. Typhi express O antigens of serogroups A, B, C1 and D, respectively.  Under the 
system currently used by the Center for Disease Control and Prevention (CDC), The World Health Organization 
(WHO) Collaborating Centre, and some other Salmonella reference laboratories. The genus consists of two main 
species based on sequence analysis differences, Salmonella enterica and Salmonella bongori (Lan et al., 2009).  
Salmonella enterica was further divided into six subspecies, designated by roman numerals I-VI and consist of 
more than 2,500 serovars or serotypes.  Among all the serovars, only about 80 are frequently associated with 
human and animal Salmonellosis (Freitas Neto et al., 2010).   Most of the strain under subspecies I are sources 
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from warm-blooded animals and humans while the remaining subdivisions and S. bongori usually originate from 
the environment. 
 
4.  Antimicrobial Definition 
Antimicrobial agents can be defined as chemicals, drugs or substances that can reduce or eliminate the growth of 
a micro-organism (CDC, 2008a).  Antibiotic resistance is defined as the ability of bacteria to stop the inhibitory 
(bacteriostatic) or killing (bacteriocidal) effects of antibiotics to which it is previously sensitive and effective 
(Lee et al., 2009).  An organism can be resistant intrinsically to an antibiotic agent due to changes in the genetic 
constituent and it can also be susceptible naturally (Forbes et al., 2002).  The antimicrobials are characterized by 
their specificity of targeting entities or organisms; an example is antiviral agent, antibacterial drugs and 
antifungal (CDC, 2008a).   
 
 In the early 20th century, penicillin was isolated from the fungus Penicillium notatum.   A decade later, the mass 
pharmaceutical production of antibiotics started that saved many lives and transformed the beginning for modern 
medicine.  Penicillin was widely available commercially in 1943, and the demand grew drastically.  It was 
perceived as a miracle drug and people developed generalized expectations for a quick and rapid cure. 
Unfortunately, the rampaged used of the antibiotics led to the development of resistance (Levy, 2002).   Over the 
years, there was increasing concern about the prevalence of resistance that was reported in many pathogens, 
spreading rapidly in different geographical regions of the world (Byarugaba, 2005).  This has been as a result of 
selective pressures of antimicrobial use, changes in microbial characteristics, and technological changes that 
enhanced the modern development and transmission of drug-resistant microbes.  At the same time, antimicrobial 
resistance is a natural occurring phenomenon, and it is often enhanced as a result of infectious etiological agents’ 
adaptation and exposure to antimicrobials used in humans and veterinary medicine or widespread use in 
agricultural farm and disinfectants at household levels (Walsh, 2000). 
 
However, the most concerning aspect of antimicrobial resistance is the multidrug resistance of pathogens, which 
makes the choice of antimicrobials more difficult in the therapy of the clinical disease.   
 
5.  Mechanism of antibiotic resistance in Salmonella 
The mechanisms for antibiotic resistance can be categorised as (i) modification or destruction of the 
antimicrobial agent, (ii) pumping the antimicrobial agent out from the cell by efflux pumps, (iii) modification or 
replacement of the antibiotic target, and (iv) decrease in cell membrane permeability.  Thus, microorganisms are 
developing resistance mechanisms by developing mutations in the gene locations of target proteins or acquiring 
mobile genetic elements carrying resistance genes such as plasmid, integrons and transposons (Walsh, 2003).  
There are many classes of antimicrobial drugs, but the most common antimicrobials that Salmonella has 
developed resistance at the present were reviewed. They are namely; aminoglycosides, β- lactams, 
chloramphenicol, quinolones, tetracyclines, sulfonamides and trimethoprim. 
 5.1 Aminoglycosides 
The aminoglycosides is active and effective against gram negative bacteria.  It can also be used in combination 
with other antibiotics drugs to have broad-spectrum of activity (Gonzalez and Spencer, 1998).   This 
combination may serve the sequence within 16S rRNA subunit of the 30S ribosomal (Mascaretti, 2003), where 
by leading to misreading codon and translation inhibition when form the binding.  Majority of aminoglycosides 
are bactericidal by killing the bacteria, while others like spectinomycin inhibit the bacterial growth known as 
bacteriostatic by mode of action (Mascaretti, 2003). 
 
There are three mechanisms by which bacteria become resistant to aminoglycosides: reduction in antibiotic 
uptake or decreased permeability, alteration of ribosomal binding sites and antibiotic modifications.  In other 
enterobacteria such as E.coli, the resistance to aminoglycoside is by efflux pumps which takes out antibiotic 
within the cell (Aires and Nikaido, 2005; Rosenberg and Nikado, 2000).  This mechanism does not play any a 
significant role in Salmonella aminoglycoside resistance, but facilitates its defiance against other antibiotics. 
Ribosomal modification has not been reported as a cause of resistance to Salmonella aminoglycosides.  The 
Salmonella uses mechanisms such as expression of plasmid-mediated aminoglycoside modifying enzymes 
against aminoglycoside (Gebreyes and Altier, 2002; Guerra, 2002).  According to Shaw et al. (1993), in his short 
review of aminoglycosides, these enzymes are categorised into three groups and are named based on reactions 
they perform; this includes acetyltransferases, phosphotransferases, and nucleotidyltransferases.  
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Aminoglycoside acetyltransferases (AAC), catalyze acetyl CoA-dependent aceytylation of an amino group 
(Mascaretti , 2003, Shaw et al., 1993).   There are four groups of this enzyme based on the areas that they alter: 
AAC (1), AAC (2’), AAC (3), and AAC (6’) (Mascaretti, 2003). Also, genes encoding these enzymes are 
typically designated aac (Vanhoof et al., 1998).  Many of this genes have been found in varieties of Salmonella 
subtypes, including Agona, Typhimurium, Newport, Typhimurium var. Copenhagen, Kentucky and 4,5,12:i:-  
(Mulvey et al., 2004; Chen et al., 2004; Doublet et al., 2004; Levings et al., 2005).   The aac genes have been 
found as part of Salmonella genomic islands (Doublet et al., 2004), integrons (Levings et al., 2005; Pai et al., 
2003), and plasmids (Guerra et al., 2001).   Aminoglycoside acetyltransferases provide resistance to tobramycin, 
gentamicin, and kanamycin (Mascaretti, 2003).   
 
These enzymes such as a aminoglycoside phosphotransferases, catalyzes ATP-dependent phosphorylation of a 
hydroxyl group (Mascaretti, 2003; Shaw et al., 1993).  This too is classification into groups depending on the 
specific sites of phosphorylation.  Groups APH (3”) and APH (6), provide resistance to streptomycin 
(Mascaretti, 2003) and have been found encoded on plasmids harbored by Salmonella (Gebreyes and Altier 
2002).  Most genes having these encoding enzymes are designated as aph (Vanhoof et al., 1998) and these genes, 
aph (3”)-Ib and aph (6)-Id, are commonly known as strA and strB, respectively (Madsen et al., 2000 and Shaw et 
al., 1993).  Salmonella serotypes Blockely, Bredeney, Agona, Anatum, Derby, Give, London, Saintpaul, Hadar, 
Heidelberg, and Typhimurium have been found to possess genes from both families (Madsen et al., 2000 and 
Pezzalla et al ., 2004).  Genes encoding enzymes of the APH (3’) subgroup provide resistance to kanamycin and 
neomycin (Mascaretti, 2003), and have been found in several Salmonella subtypes such as Enteritidis, Haardt, 
Derby (Chen et al., 2004), Typhimurium (Gebreyes and Altier, 2002), and Typhimurium var. Copenhagen 
(Frech et al., 2003).   
The nucleotidyl transferase is the final group of enzymes providing aminoglycoside resistance (Mascaretti, 2003, 
Shaw et al., 1993).  These enzymes are divided into several groups based on the site of modification and also 
target the hydroxyl groups. Genes encoding these enzymes are usually designated aad (Vanhoof et al., 1998), 
some are also designated as ant.   The gene aadA, is referred to as ant (3”) (Shaw et al., 1993), found in 
Salmonella providing resistance for streptomycin (Mascaretti, 2003). Also many of these variants genes have 
been found in serotypes Bredeney, Derby, Agona, Anatum, Enteritidis, Give, Heidelberg, Saint Paul, and 
Typhimurium (Chen et al., 2004; Madsen et al., 2000; Pezzella et al., 2004). The aadB gene, also known as ant 
(2’)-Ia (Shaw et al., 1993), confers resistance to tobramycin and gentamicin (Mascaretti, 2003).   It has been 
found in serotypes Typhimurium and Typhimurium var Copenhagen (Carattoli et al., 2001; Antunes et al., 2005; 
Frech et al., 2003).  Both aadA and aadB have been found in integron-borne gene cassettes (Pezzalla et al., 2004; 
Winokur et al., 2001). 
 
5.2  Beta-lactams 
These family groups comprised of penicillins derivatives, cephalosporins, carbapenems and monobactams (Petri, 
2006; Queenan and Bush, 2007).  Their mechanism of action is by interfering penicillin-binding proteins (PBPs) 
with a group of seven proteins.  These proteins facilitate the synthesis of peptidoglycan, an important component 
of the bacterial cell wall. Beta lactams are generally considered bactericidal; also the activity varies among 
betalactams, organisms, and target PBP.   Furthermore for enteric bacteria such as Salmonella and E. coli, it 
appears that inhibition of the essential PBPs, 1 through 3, leads to bactericidals activity.   Many organisms are 
now becoming resistant to ampicillin and methicillin due to their wide clinical use (Angulo et al., 2000).   Also, 
as a consequent of this, cephalosporins were developed as second class of beta lactams.  There is close structural 
similarity between Cephalosporins and penicillins, but there have a 6, rather than a 5 member beta- lactam ring 
(Hornish and Kotarski, 2000).   These structural differences provide cephalosporins with a wide range of 
efficacy and stability in the present beta-lactamases.  Cephalosporins are grouped into four generations according 
to their spectrum of activity and the time of the agent’s introduction (Hornish and Kotarski, 2000).   The 
increased use of the drugs for treatment has made more resistant.  Carbapenems is the latest beta-lactams group 
to be discovered.  They are paired with beta-lactamase inhibitors sometimes, and are cross between the 5-
member beta-lactam ring of penicillins and with cephalosporins extra functional group (Mascaretti, 2003).  The 
carbapenems are more effective against gram positive and gram negative bacteria than other beta-lactam family, 
and are very stable against beta-lactamases, because they diffuse easily in bacteria are considered as broad 
spectrum β-lactam antibiotic. For this reason, their clinical used are reserved for a multidrug resistance bacteria.  
There is an indication of resistance to carbapenems such as imipenem by Salmonella species (Arman-Lefevre et 
al., 2003; Mariagou et al., 2003).   At the time the beta-lactams transverse the bacterial cell wall to reach their 
targets PBP by using two porins OmpC and OmpF with facilitate the passage (Jaffe et al., 1982).   Studies have 
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shown that decreases in either OmpF or OmpC porin levels have generated an increase in resistance (Bellido et 
al., 1989; Medeiros et al., 1987).  In other report, decrease in porin content found that the reduction in OmpF and 
OmpD porin expression actually lead to decreased resistance to most beta-lactams other than mecillinam and 
imipenem in Salmonella envB mutants, this is due to the other effect of envB mutation on the organisms 
(Oppezzo et al., 1991).   
To date, there is growing concern about more than 340 beta lactamases resistance genes, such as blaTEM, 
blaOXA, blaPER, blaPSE, blaSHV, blaCTX-M, and blaCMY, while some are more prevalent in Salmonella 
globally (Armand-Lefevre et al., 2003).  In Salmonella, the secretion of a beta-lactamase is the common 
mechanism of resistance to beta-lactamases. These enzyme acts by hydrolyzing the structural rings of the B-
lactam, by producing beta amino acids with no antimicrobial activity. In Salmonella encoding genes are found or 
carried on the plasmid (Mascaretti, 2003).  
 
Ambler classification of beta lactamases is the most widely used. It divides blactamases into four classes (A, B, 
C and D) based upon their sequences of amino acid (Mascaretti, 2003). Moreover, in Salmonella the class A 
beta- lactamases are the most commonly found class of beta-lactamases.  They provide a range of resistance 
against penicillins, cephalosproins, and carbapenems and are plasmid encoded. There are many more different 
gene families encoding for enzymes in this class, with TEM being the most common among Salmonella. The 
genes blaTEM-1 and blaTEM-52 have been found in many Salmonella serotypes including Enteritidis, Dublin, 
Haadrt, Muenchen, Panama and Typhimurium (Chen et al., 2004, Gebreyes and Thakur, 2005).  The blaKPC-2 
is a class A beta- lactamase gene, which is more active resistant to imipenem, was recently discovered in a 
Salmonella serotype Cubana isolate (Miriagou et al., 2003).  The emergence of another class A beta-lactamases, 
known as cefotaximases (CTX-M), which confer resistance to ampicillin and cephalosporins, is of clinical 
importance to watch (Batchelor et al., 2005).  Also in Salmonella serotypes Anatum, Enteritidis, Stanley, 
Typhimurium, and Virchow, BlaCTX-M variants have been identified in isolates from other European countries 
(Batchelor et al., 2005, Weill et al., 2004).   
 
The class C beta-lactamases is the second most common class of beta-lactamases that provides resistance against 
cephalosporins such as cefoxitin and ceftiofur that are encoded by chromosomal ampC genes.  These genes are 
harbored in plasmids carried by Salmonella instead Salmonella carries no chromosomal ampC gene, (Morosini et 
al., 2000).  However, more research is primarily focused on blaCMY-2 which is presence and has been 
associated with resistance to ceftiofur (Alcaine et al., 2005). 
Ceftiofur is a group of third generation cephalosporin and are closely related to ceftriaxone.  The resistant to this 
drugs and the spread of the gene is a public health problem worldwide as ceftraxone is a drug choice for treating 
Salmonella infection in infant. Likewise many Salmonella serotype such as Typhimurium, Agona, and Newport 
(Alcaine et al., 2005, Doublet et al., 2004), have been found to carry this resistance genes (Alcaine et al., 2005, 
Winokur et al., 2000).  
 
The Class B beta-lactamas like Metallo-beta-lactamases, this enzyme provides resistance to all beta-lactam 
antibiotics, including carbapenems (imipenem) and are usually encoded chromosomally, though plasmid 
mediated class B beta-lactamases, such as IMP-1 and VIM-1, do exist (Mascaretti, 2003). These Class B beta-
lactamases are not commonly found in Salmonella. At last Class D beta-lactamases are uncommon among 
Salmonella. This class of enzymes provides resistance to lactams closely related to oxacillin, such as cloxacillin 
and methicillin. The gene blaOXA-1 was found in a Salmonella serotype Paratyphi (Cabrera et al., 2004) and 
blaOXA-30 has been found in serotypes Muenchen and Typhimurium (Antunes et al., 2004; Hanson et al., 
2002). 
     
5.3 Chloromphenicol 
Chloramphenicol is specific and potent inhibitor of protein by binding to the peptidyltransferase center of the 50s 
ribosomal unit, thus preventing formation of peptide bonds (Mascaretti, 2003).  As a result of the binding to 
enzymes, the drugs will prevent elongation of the peptides.  
 
Chloramphenicol is a broad-spectrum antibiotic against both the gram negative and gram positive bacteria and it 
is effectiveness and ability to cross the blood-brain barrier makes it the drugs of choice for systematic infections 
therapy.  The most serious adverse effect of the drugs can cause damage in bone marrow and aplastic anemia.  
Chloramphenicol is being use in human and veterinary medicine for the treatment of Salmonellosis for a long 
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time and has now given rise to resistance strains.  There are two mechanisms in which Salmonella resistance to 
chloramphenicol is conferred: (i) by the plasmid-located enzymes called chloramphenicol acetyltransferases 
(CAT) or nonenzymatic chloramphenicol resistance gene cm1A and (ii) Efflux pump in which the antibiotic is 
removed. Salmonella Typhi isolates have been found to encoding genes for CAT and are plasmid-borne (Guerra 
et al., 2000; Shanahan et al., 2000).  However, CAT genes, such as cat1 and cat2, have also been found in 
Salmonella serotypes such as Derby, Haardy, Enteritidis and Typhimurium (Chen et al., 2004).  The cmlA 
(Cabrera et al., 2004) and floR (White et al., 2001) are closely related genes encoded in Chloramphenicol eflux 
pumps in Salmonella that have been reported.  Also floR genes appear to be very widespread in Salmonella, 
whereas cmlA is less widely distributed.  There are various Salmonella serotypes such as Agona, Kiambo, 
Albany, Newport, Typhimurium, Typhimurium var Copenhagen that have been found to carry floR (Alcaine et 
al., 2005; Cabrera et al., 2004; Doublet et al., 2004; Meunier et al., 2003).  This genes has been found in 
Salmonella genomic islands (Weill, et al., 2005;), as well as in many different plasmids due to a highly mobility 
(Meunier et al., 2003), and closely associated with multi-drug resistance (Alcaine et al., 2005; Doublet et al., 
2004) most likely due to its presence on plasmids carrying multiple resistance genes. 
 
5.4  Quinolones 
There are many generations of quinolones, which are more effective against bacterial infection. However, their 
mode of action varies, the early and late generation of quinolones target DNA gyrase and DNA topoisomerase 
IV (Mascaretti, 2003). 
 
Quinolone’s mechanism of action is quite complex and not well comprehended (Mascaretti, 2003).  Many 
studies have indicated that quinolones target topoisomerases. The antibiotic does not actually bind to the 
topoisomerase, but to the double stranded DNA in the topisomerase complex (Shen and Pernet, 1985).  While 
there are reports of Salmonella with low-level resistance to other Quinolones and resistance to nalidixic acid 
(Breuil et al., 2000; Molbak et al., 1999), a high- level resistance to quinolones is still rare (Olsen et al., 2001).  
 
Salmonella resistance to quinolone has been classified into to two mechanisms. The first is the two gyrA and 
gyrB,  genes which encode for the subunits of DNA gyrase, will be  targeting mutations in the quinolone 
resistance-determining region (QRDR), and in the parC subunit of topisomerase IV (Baucheron et al., 2004; 
Casin et al., 2003; Levy et al., 2004).  Also the second mode of action involves changes in the AcrAB-TolC 
efflux system expression, as a result of mutations in the regulator genes of this system, that due to over 
expression of this efflux system (Koutsolioutsou et al., 2001; Levy et al., 2004; Olliver et al., 2005), which make 
quinolone sensitivity decreased.  However, it is an accumulation of all these mutations that provides resistance, 
because no one mutation confers high-level resistance to quinolones (Heisig, 1993).  At the present time, 
acquiring multiple of unlinked mutations by Salmonella are necessary, and that some of those mutations reduce 
fitness, particularly those involved in the regulation of the efflux pump (Giraud et al ., 2003).  While in some 
bacterial organism, such as E. coli and Klebsiella pneumonia (Wang et al., 2004), the expression of a plasmid 
mediated gene called qnr has also been linked to quinolone resistance (Li et al., 2005).  The gene expresses a 
protein that appears to bind to DNA-gyrase and protect it from quinolone inhibition (Li et al., 2005).  The study 
conducted on plasmids harboring qnr showed that it could be transferred via conjugation from other bacterial 
species to Salmonella (Martinez et al., 2005).  While a recent study indicated that the spread of such plasmids to 
Salmonella has occurred and plasmid-mediated quinolone resistances in Salmonella are rare (Cheung et al., 
2005). The occurrence of plasmid-mediated quinolone resistance in Salmonella appears to be a very important 
emerging public health concern globally.  Other resistance genes have been found harboring plasmids qnr in 
Salmonella (Martinez-Martinez et al., 1998). 
 
 5.5  Tetracycline 
Tetrecycline is clinically known as broad spectrum antibiotic and is effective against many gram positive and 
negative bacteria such as chlamydias, mycoplasms, and even some protozoa (Chopra and Roberts, 2001; 
Mascaretti, 2003).  Tetracyclines mostly act by stopping the binding of tRNA to the A site of the 30S ribosomal 
subunit by inhibiting protein synthesis (Mascaretti, 2003).  However, the rise of antibiotic resistant bacteria has 
severely limited the use of tetracycline. Many finding indicated that tetracycline resistance in Salmonella can be 
attributed to the production of an energy dependent efflux pump to remove the antibiotic from within the cell. 
The modification of the ribosomal target, enzymatic inactivation of tetracycline, and other mechanism of 
resistance, have been documented in other bacterial species but has yet to be reported in Salmonella (Chopra and 
Roberts, 2001; Mascaretti, 2003). 
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 In Salmonella several different tetracycline (tet) genes have been discovered as conferring resistance to 
tetracyclines in Salmonella serotypes.  The most common types of tet genes belong to classes A, B, C, D, and G 
(Chopra and Roberts 2001).   Also the tet (G) gene was found in salmonella genomic island 1, located within the 
S. enterica serotype Typhimurium DT104 chromosome (Boyd et al., 2001; Cloeckaert and  Schwarz, 2001).  The 
tet (A) gene was found on plasmids as well as on the chromosome, whereas the genes tet(B), tet(C), and tet(D) 
were identified on the chromosomes of many Salmonella enterica serotypes, including Typhimurium, Saintpaul, 
Enteritidis, Hadar and Choleraesuis (Frech and Schwarz, 2000).  It has been found in serotypes Agona, Anatum, 
Blockley, Bredeney, Colorado, Derby, Give, Haardt, Heidelberg, Infantis, Orion, Seftenberg, (Chen et al., 2004; 
Pezzella et al., 2004).  The tet(B) gene is very common.  It has been found in serotypes Agona, Dublin, 
Choleraesuis, Heidelberg, Typhimurium (Chen et al., 2004; Frech and Schwarz, 2000; Guerra et al., 2002).  Like 
tet(A), tet(B) genes has also been located on transferable plasmids (Guerra et al., 2002). These genes are easily 
transferred and are wide spread among Salmonella.  Also, most are tend to be found in isolates that having multi-
drug resistance (Carattoli et al., 2002; Chen et al., 2004; Pezzella et al., 2004), making them an important 
identification marker in identifying potentially serious of the Salmonella infections. 
 
5.7  Sulfonamide and trimethoprime  
These classes of antibiotics are bacteriostatic and it mode of action is by competitively inhibiting enzymes 
involved in the synthesis of tetrahydrofolic acid.  Sulfonamides inhibit dihyrdropteroate synthetase (DHPS), 
while trimethoprim inhibits dihydrofolate reductase (DHFR) (Mascaretti, 2003).  The resistance of Salmonella to 
sulfonamide has been attributed to the presence of an extra sul gene which expresses an insensitive form of 
DHPS (Antunes et al., 2005; Mascaretti, 2003).  The sul1, sul2, and sul3 are the three main genes have been 
indentified; The gene sul1 has been harbored by a wide range of Salmonella serotypes such as Enteritidis, Hadar, 
Heidelberg, Orion, Rissen, Agona, Albany, Derby, Djugu, and Typhimurium (Antunes et al., 2005; Chen et al., 
2004; Doublet et al., 2004).  The class I integrons that contain other resistance gene, have often been associated 
with this genes (Guerra et al., 2002; Sandvang et al., 1998).  At time these integron gene cassettes have been 
located on transferable plasmids (Guerra et al., 2002) and as part of Salmonella genomic island variants (Boyd et 
al., 2002; Doublet et al., 2004).  While sometimes discovred in isolates also harboring sul1 (Antunes et al., 2005; 
Chen et al., 2004), sul2 appears to relate with plasmids, but not class I integrons (Antunes et al., 2005). Many 
Salmonella serotypes Enteritidis, Agona, and Typhimurium isolates have been found habouring sul2 (Chen et 
al., 2004). 
 
Also sul3 has only been recently known to be associated with plasmids and class I integrons in Salmonella 
(Guerra et al., 2002; Antunes et al., 2005), sul3 has already been found in many serotypes 4,5,12:i:-, Anatum, 
Bradenburg, Heidelberg, Rissen, Agonaand Typhimurium (Antunes et al., 2005, Guerra et al., 2002).  
Trimethoprim resistance is attributed to the activity of DHFR (Mascaretti, 2003). Serotypes known to have 
trimethoprim resistance genes are 4,5,12:i:-, Agona, Djugu, Hadar, Neport, Rissen Albany, Derby, and 
Typhimirium (Antunes et al., 2006; Doublet  et al., 2004; Doublet et al., 2003; Martinez et al., 2005).  Likewise, 
these genes have been found as part of integron-borne gene cassettes also associated with sul1 and sul3 (Antunes 
et al., 2005), on transferable plasmids carrying other resistance genes (Villa and Carattoli, 2005), and Salmonella 
genomic islands (Doublet et al., 2004). 
 
6.  Integrons 
These are two component gene capture and dissemination system, initially discovered in relation to antibiotic 
resistance and are found in plasmids, chromosomes and transposons.  The elements are divided in to three (3) 
classes based on the general gene arrangement that they encode and IntI integrase.  Before 2001, there were only 
four classes of integrons which had been known, mainly from clinical isolates.  These are integrons class-1, 
class-2, class-3 and class-4 (Mazel and Davies, 1998; Stokes and Hall 1989; Collis et al., 2002).  The most 
prevalent integrons among clinical strains are Class-1 integrons (Fluit and Schmitz, 1999).  They are unique and 
characterized by the presence of two conserved sequences, known as the 5’CS and 3’CS, which flank a variable 
region (Bennett, 1999).  The essential component of class 1 integrone are integrase gene (intI1) and a gene 
cassette attachment site (attI) are contained in the 5'-conserved region.  The 3'-conserved region is identified by 
the presence of a sulphonamides resistance gene (sul1), a quaternary ammonium compound resistance gene 
(qacE∆1), and open reading frames orf5 and orf6, with unknown functions.  The class-1 integrons can code for 
one or more gene cassettes in the variable region (Hall and Stokes, 1993).   
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The presence of class 1 integron have been reported in several Salmonella serotypes, such as Salmonella 
Serotypes Typhimurium, Enteritidis, Ohio, Panama, Virchow, Hadar, and Muenhen (Guerra et al., 2000.  The 
development of multidrug resistance depends on the capacity of integrons to cluster the gene cassettes and to 
express antimicrobial resistance genes.  Mostly integrons are not mobile by themselves, but may be integrated 
into transposable elements, such as Tn1696 or located on plasmids, and then can be spread with these elements 
(Schwarz et al., 2006).  Antunes et al. (2006) have reported the presence of class 1 and 2 integrons in Salmonella 
serotypes Typhimurium, Enteritidis, Muenhen, Rissen, Derby, Saintpaul, Heidelberg, Bredeney, Brandenburg, 
Brikama and IIIb: 65:1v:enxz15 isolated from humans, food products and environment. 
 
7.  Antibiotic resistance Salmonella 
The misuse of antimicrobial agents as chemotherapy in human and veterinary medicine or as growth promoter in 
food animals can potentially lead to widespread dissemination of antimicrobial resistance Salmonella and other 
pathogens via mobile genetic elements (Bouchrift et al., 2009).  Recent findings showed the consequences of 
antibiotic resistant on human health. These consequences can be divided into two categories: first, the infections 
that may not have occurred and secondly, the high incidence of treatment failures and increase in the severity of 
disease (WHO, 2009).   Moreover, resistance can spread from non-human sources to human by various routes 
such as animal, water and contaminated foods.  However, contact with Salmonella carrier animal is the most 
important pathway in transmission of resistance to humans.  Resistance to combinations of many classes of 
antimicrobial agents in Salmonella has led to the re-emergence of multidrug resistance Salmonella (MDR) 
strains that may pose a risk to humans (White et al., 2001;s O’Brient, 2002).  Many research indicate that in the 
last two decades the occurrence of MDR strains in different Salmonella serovars. Also, MDR Salmonella strains 
have been found to be of many serotypes such as Agona, Anatum, Pullorum, Schwarzengrund, Choleraesuis, 
Derby, Dublin, Heidelberg, Kentucky, Newport, Senftenberg, Typhimurium, and Uganda (Chen et al., 2004; 
Gebreyes and Thakur, 2005; Zhao et al., 2008).  Nowadays, interest in antimicrobial resistance Salmonella has 
increased.  The emergence and persistence of antibiotic resistance in Salmonella spp. continue to pose serious 
risks to human health (Joseph et al., 2008).  The most common Salmonella serotype having multidrug resistance 
is S. Typhimurium definitive phage type DT104 found to display a phenotype of resistance to ampicillin, 
chloramphenicol, streptomycin, sulfonamides, and tetracycline (ACSSuT), these are the most common drug 
classes used in veterinary medicine (Mulvey et al., 2006).  Later follow by other serotypes such as S. Typhi, S. 
Paratyphi, S. Infantis, S. Uganda, S. Agona, and S. Newport, S. Hadar, S. Heidelberg are exhibited multidrug 
resistance in addition to S. Typhimurium (Holt et al., 2007; Nógrády et al., 2007; Zhao et al., 2007). 
 
8.  Conclusions 
Regular epidemiological studies may help in monitoring the occurrence of salmonellosis and in developing firm 
strategies for its prevention.  The knowledge and understanding about factors that contribute to the occurrence, 
distribution and establishment of the Salmonella disease may be helpful in eliminating its survival in the 
environment, thereby protecting and promoting public health.  Other important preventive measures include 
improvements in sanitation, availability of clean drinking water, promotion of safe food handling practices, and 
public health education.  In view of the re-emergence of sensitivity to first-line drugs, large-scale systematic 
studies are required to determine whether these drugs can again be used for the treatment of Salmonellosis in 
developing countries.  The occurrence of antibiotic resistances in the Salmonella is worrisome as it could pose a 
risk to animal and human health.  
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